Henry H. Freedman, Ph.D., 90, of Princeton, died June 19, 2009 at the University Medical Center in Princeton.
Dr. Freedman retired from AstraZeneca as Corporate Vice-President for Pharmaceutical Research and Development and Regulatory Affairs. He was responsible for developing the heart drug Tenormin, the breast cancer drug Nolvadex, and the surgical anesthetic Diprivan. He was previously employed at Warner-Lambert. He also served as President of the Reticuloendothelial Society.
Born in New York City, he attended Townsend Harris High School, where he was yearbook art editor. He studied art at City College and Cooper Union prior to specializing in science at New York University, where he received his Ph.D. in physiology. He served as First Lieutenant in the Army Air Corps during World War II.
Dr. Freedman was an avid dog lover and supporter of SAVE. He owned a succession of five Bouviers des Flandres. He also loved to garden.
He is survived by his wife of 60 years, Barbara W. Freedman, of Princeton; his son, Dr. Jonathan E. Freedman, of Boston; and his sister-in-law, Gabriella Freedman, of West Palm Beach, Fla.